Copptech: A Antiviral Biotech
The project's goal is to provide Covid-19 crisis response financing for sustaining andpromoting Copptech's expansion to improve households and business resilience against Covid-19. Copptech develops and manufactures chemicals based on zinc and copper that neutralize the effect of the Cov-SARS-2 virus in different types of surfaces, such as wood polymers and metals. Its requesting a loan from LIFESS to comply with a drastic increase in demand for its products.

Project Detail

Country

Chile

Project Number

CH-L1154

Approval Date

November 30, 2020

Project Status

Closed

Project Type

Loan Operation

Sector

PRIVATE FIRMS AND SME DEVELOPMENT

Subsector

ENTERPRISE DEVELOPMENT, CLUSTERS AND INNOVATION

Lending Instrument

Multilateral Investment Fund Instrument

Lending Instrument Code

MIF

Modality

-

Facility Type

-

Environmental and Social Impact Category (ESIC)

Category B13: Uncategorized Directive B.13

Total Cost

USD 1,500,000.00

Country Counterpart Financing

USD 0.00

Original Amount Approved

USD 1,500,000.00
Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
5166/MS-CH Non-Sovereign Guaranteed USD - United States Dollar MIF-Small Enterprise Investment Fund MIF Financing
Operation Number 5166/MS-CH
  • Lending Type: Non-Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: MIF-Small Enterprise Investment Fund
  • Financial Instrument: MIF Financing

Can’t find a document? Request information

 Implementation Phase
https://www.iadb.org/document.cfm?id=EZSHARE-2075448529-1
Donors Memorandum
CH-L1154 Resumen del proyecto.pdf
Feb. 15, 2022
English
https://www.iadb.org/document.cfm?id=EZSHARE-2075448529-2
Donors Memorandum
CH-L1154 Project Summary.pdf
Feb. 15, 2022
English

Have an Environmental or Social issue related to IDB projects? File a Complaint